Interviews

McMaster Perspective more

If you could decrease the risk of MI by a quarter, would you do it?
Dr Jean-Claude Tardif from the Montreal Heart Institute connects with Dr Roman Jaeschke to talk about the most recent RCT findings on the use of colchicine in CAD.
Iodine or chlorhexidine as a skin antiseptic?
Dr Gerard Slobogean joins Dr Roman Jaeschke to discuss a recent paper on the use of iodine povacrylex in alcohol versus chlorhexidine in alcohol to prevent surgical site infection.

Pharmacotherapy in patients with HF
Are there differences in pharmacotherapy for patients with heart failure depending on their age (advanced vs very advanced)? Which potential adverse effects of drugs should be kept in mind in those groups?
Diagnostic testing in patients with suspected HFpEF
Which diagnostic testing should be performed in patients with suspected HFpEF?

The future of type 2 diabetes treatment
With the current progress of medicine, can we expect that the use of insulin in people with type 2 diabetes will soon pass into history and the only injection therapy will involve effective drugs from the glucagon-like peptide-1 (GLP-1) receptor agonists, promoting significant weight loss?
Concentrated long-acting insulin analogues in type 2 diabetes
What is the place of long-acting insulin analogues with higher than standard concentrations (200 IU/mL and 300 IU/mL) in the treatment of type 2 diabetes? In which patients should we expect the benefits to justify recommending the drug despite the higher cost to the patient?

Cannabinoids in IBD
What is the role of cannabinoids in inflammatory bowel disease (IBD) management?
Diet and IBD
Is there any diet that reduces or sustains the remission of inflammatory bowel disease (IBD) in adult patients?

Environmental precautions for patients with chronic neutropenia
Are there any environmental precautions (including those related to diet) that should be followed by patients with chronic neutropenia?
Lymphopenia of undetermined etiology
What should be the diagnostic approach to lymphopenia of undetermined etiology?

Nasal high-flow therapy in ARDS
What is the role of nasal high-flow therapy in the treatment of acute respiratory distress syndrome (ARDS)?
Methods to support NIV
Which methods are useful in supporting noninvasive ventilation (NIV)?

Long COVID and pain
What type of pain is most prevalent in long COVID and how to manage it?
Important recent reports in infectious diseases
Have there been any breakthrough reports or any new important guidelines in the field of infectious diseases?

CKD and obesity
How big a problem is the coexistence of chronic kidney disease (CKD) and obesity? In a person starting renal replacement therapy, is obesity or malnutrition a greater risk?
Challenges of novel oncology therapies in kidney disease
What new problems have arisen in relation to novel oncology therapies in patients with coexisting kidney disease?

Management of patients with epilepsy
Could you please summarize the key advice for neurologists treating patients with drug-resistant epilepsy?
Cannabinoids in patients with epilepsy
What is the current place of cannabidiol and other cannabinoids in the treatment of epilepsy? How often are OTC cannabinoid preparations used by patients with epilepsy in North America? How does it affect the clinical management of epilepsy?

The 3 most important recent advances in treating cancer pain with opioids
Dr Per Sjøgren from University of Copenhagen, Denmark, shares his views on the 3 most important recent advances in treating cancer pain with opioids.
CA 19-9 in pancreatic cancer screening
What is the role of cancer antigen (CA) 19-9 in screening for pancreatic cancer?

Diagnostic workup of eosinophilic bronchitis
Can an increased level of eosinophils in the nasal cytology of a person with chronic cough indicate eosinophilic bronchitis as its cause?
ACEI treatment and chronic cough
What is the typical time between starting the ACEI treatment and the occurrence of cough? How long should we wait for suspected ACEI-induced cough to resolve?

Are glucocorticoids still the mainstay of treatment in polymyalgia rheumatica and giant cell arteritis?
Are glucocorticoids still the mainstay of treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), or should we consider glucocorticoid-sparing agents earlier than before?
Giant cell arteritis and Takayasu arteritis: Differential diagnosis
How to differentiate giant cell arteritis (GCA) from Takayasu arteritis?

Medical cannabis and abuse of psychoactive cannabinoids
Is there a risk that the legal use of medical cannabis will affect the abuse of psychoactive cannabinoids?
Medical cannabis and alcohol or drug addiction
Can we use medical cannabis in patients with alcohol or drug addiction?

Thromboprophylaxis in elderly patients with frailty syndrome
How to prevent thrombosis in an elderly patient with frailty syndrome in the ICU?
Thromboprophylaxis in individuals with obesity in the ICU
How to prevent thrombosis in a patient with obesity in the intensive care unit?

Evaluation for rashes in people with diverse skin colors
In individuals with light-toned skin types it is easy to notice skin lesions such as erythema. Does the physical examination for rashes differ between people with different skin tones/diverse skin colors?
Internal organ involvement in drug hypersensitivity skin reactions
When to expect internal organ involvement in patients with a cutaneous drug hypersensitivity reaction? What tests could be useful?